Combination therapy with carboplatin and paclitaxel for small cell lung cancer
ConclusionA combination of carboplatin plus paclitaxel as second-line chemotherapy is effective and feasible in patients with SCLC, especially in those with ILD.
Source: Respiratory Investigation - Category: Respiratory Medicine Source Type: research
More News: Anemia | Brain | Cancer | Cancer & Oncology | Chemotherapy | Hematology | Interstitial Lung Disease | Lung Cancer | Neurology | Palliative | Radiation Therapy | Respiratory Medicine | Small Cell Lung Cancer | Thrombocytopenia | Toxicology